DMEMEDS shared post via Reuters: Roche says wins priority review for Avastin in cervical cancer

ZURICH (Reuters) - Swiss drugmaker Roche said U.S. health regulators have granted a priority review of its Avastin drug when combined with chemotherapy to treat women with cervical cancer. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/dPkd4fZZb4Q/story01.htm

Read More